Get started
Author

Anna Schuh

Liquid biopsy for the diagnosis of EBV-positive Burkitt’s lymphoma in endemic areas
2026 · Clara Chamba, Heavenlight Christopher, et al. · Nature Medicine · 3
Media coverage and PATHFINDER2: hype, simplification, and free advertising
2025 · Clare Turnbull, Anna Schuh, et al. · The Lancet Oncology · 3
Africa’s emerging role in precision oncology: translational insights from the harnessing functional genomics in cancer research conference, Windhoek, 23-26 September 2025
2026 · Charlize L. Rix, Eliud Buchard Buberwa, et al. · BMC Proceedings · 1
PDF
Minimally acceptable criteria and required sample size for an accuracy study of non-invasive prenatal testing of sickle cell disease in screen positive women in England: results of a decision tree model
2026 · Vittoria Vardanega, Ania Bobrowska, et al. · Diagnostic and Prognostic Research · 1
PDF
Modelling the cost-effectiveness of non-invasive prenatal testing in the English sickle cell and thalassaemia screening pathway
2026 · Vittoria Vardanega, Ania Bobrowska, et al. · Diagnostic and Prognostic Research · 1
PDF
Is liquid biopsy a cost-effective method to diagnose Burkitt Lymphoma in children and young adults? A health economic evaluation in Tanzania
2026 · Jingjing Jiang, Liz Morrell, et al. · BMC Medicine · 1
A call to standardize the definition of countries with a high-burden of sickle cell disease
2026 · Amelia Seabold, Igor Rudan, et al. · Journal of sickle cell disease. · 1
Addition of Rituximab to First-Line Treatment of Burkitt Lymphoma in Children and Young Adults in Tanzania: A Cost-Utility Analysis
2026 · Liz Morrell, William F. Mawalla, et al. · JCO Global Oncology
How advances in machine learning drive early detection and risk prediction of early-onset colorectal cancer
2026 · Sudha S. Murthy, Anna Schuh · Frontiers in Oncology
PDF
Pre-treatment circulating tumour DNA (ctDNA) to predict survival and aid decision-making in head and neck cancer patients: 5-year outcome analysis.
2026 · Sumrit Bola, Anthony Cutts, et al. · Journal of Clinical Oncology
Additional file 4 of Is liquid biopsy a cost-effective method to diagnose Burkitt Lymphoma in children and young adults? A health economic evaluation in Tanzania
2026 · Jiang, Jingjing, Morrell, Liz, et al. · Figshare
Additional file 7 of Is liquid biopsy a cost-effective method to diagnose Burkitt Lymphoma in children and young adults? A health economic evaluation in Tanzania
2026 · Jiang, Jingjing, Morrell, Liz, et al. · Figshare
Additional file 5 of Is liquid biopsy a cost-effective method to diagnose Burkitt Lymphoma in children and young adults? A health economic evaluation in Tanzania
2026 · Jiang, Jingjing, Morrell, Liz, et al. · Figshare
Is liquid biopsy a cost-effective method to diagnose Burkitt Lymphoma in children and young adults? A health economic evaluation in Tanzania
2026 · Jiang, Jingjing, Morrell, Liz, et al. · Figshare
Additional file 6 of Is liquid biopsy a cost-effective method to diagnose Burkitt Lymphoma in children and young adults? A health economic evaluation in Tanzania
2026 · Jiang, Jingjing, Morrell, Liz, et al. · Figshare
Additional file 2 of Is liquid biopsy a cost-effective method to diagnose Burkitt Lymphoma in children and young adults? A health economic evaluation in Tanzania
2026 · Jiang, Jingjing, Morrell, Liz, et al. · Figshare
Additional file 3 of Is liquid biopsy a cost-effective method to diagnose Burkitt Lymphoma in children and young adults? A health economic evaluation in Tanzania
2026 · Jiang, Jingjing, Morrell, Liz, et al. · Figshare
Additional file 1 of Is liquid biopsy a cost-effective method to diagnose Burkitt Lymphoma in children and young adults? A health economic evaluation in Tanzania
2026 · Jiang, Jingjing, Morrell, Liz, et al. · Figshare
Works count: 20
Citation count: 12
H-index: 2
I10-index:
Year
Topic
Type